Alex Reed
Co-founder and CEO, Fluence Analytics
Imagine a system that could monitor a manufacturing facility in real time. Instead of a company pulling a sample of a product every hour or two for quality control, every single product is checked, every single second.
It would be a game changer for manufacturers, and it’s exactly what Fluence Analytics has done. The company’s monitoring system is currently in use at an industrial scale.
Alex Reed is the son in the father-and-son duo behind the company (formerly known as Advanced Polymer Monitoring Technologies since its founding in 2012) whose products are used by biopharmaceutical and polymer industries. Working alongside his father, Tulane physics professor Wayne Reed since he was 12 years old, Alex Reed says the two “help create the products that make modern life possible.”
In May, Fluence Analytics announced they had received Series A funding led by venture capital firm Energy Innovation Capital (EIC). The company operates out of a 6,700-square-foot facility at 1078 South Gayoso Street in Gert Town.
On the biopharmaceutical end, the Reeds have developed a lab instrument capable of measuring the pharmaceutical stability of therapeutic proteins.
“The pharmaceutical industry is one of rapid growth and change and there are a lot of knowledge gaps when it comes to how a protein behaves when not in the body,” says Alex Reed. “What happens to a drug when it’s in transit? How is it affected by banging around in a truck? We can provide answers to these types of questions and help a company engineer a more robust formulation.”
